Indian Pharma industry moving towards formulations

Indian Pharma industry is slowing moving up the value chain. Earlier it used to manufacture active pharmaceutical ingredient at low cost compared to world. Now with competition from China, which provides API at 15-20% low cost, it makes sense to shift focus elsewhere. Many top companies like Lupin, Novartis, Ranbaxy have less revenue stream from API than from formulations. There could also be the reason that formulation business has grown faster than APIs for some companies. API is low scale commodity with low margin. Moreover, with a large number of patent expiries in developed markets like the US and Europe, Indian companies, with skills to develop and manufacture low-cost generic drugs, see a much more lucrative opportunity there than utilising their capacities for manufacturing APIs.
Read More

  • No Image
    Parenteral Drugs India Ltd

    Parenteral Drugs (India) Limited is involved in research, production and manufacturing of pharmaceutical products viz. intravenous infusion, tablets, capsules, liquids syrups, i

  • No Image
    Parshva Chemicals

    Parshva Chemicals is a manufacturer, exporter and supplier of a wide range of industrial chemicals. Their products include copper chloride anhydrous, copper chloride, cupric chl

  • No Image
    Pegasus Farmaco Pvt Ltd

    Pegasus Farmaco Pvt Ltd is a pharmaceutical company based at Hyderabad, India. The company was incorporated in 1995 by Mr Raghuveer Beti, Ms. Neeraja Beti, Mr. Surinder Vuthoori

  • No Image
    Penam Laboratories Pvt Ltd

    Penam Laboratories Pvt Ltd is engaged in the manufacturing, including contract manufacturing, of bulk drugs, Active Pharmaceutical Ingredients (APIs), API intermediates and form

  • No Image
    Pentagon Labs Ltd

    Pentagon Labs Ltd was incorporated in Oct. 1994. The company is engaged in manufacturing of Intravenous Fluids. PLL has a production unit in Dewas, Madhya Pradesh. The registere